E. Tapper

Epidemiology · 2018–2021

A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom E. Tapper trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Z. Younossi

Papers from E. Tapper's perspective

Ordered by how strongly the researchers E. Tapper trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Global burden of alcoholic liver diseases. (Journal of Hepatology)
  2. EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease (Obesity Facts)
  3. Of markets and rights: Discourse in the 2008 and 2013 Global Action Plan for the Prevention and Control of Noncommunicable Diseases
  4. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The… (Journal of the American College of Cardiology)
  5. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease (Hepatology)
  6. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. (American Journal of Epidemiology)
  7. Nonalcoholic fatty liver disease. (Revista de Gastroenterología de México)
  8. Nonalcoholic fatty liver disease: a systematic review. (Journal of the American Medical Association (JAMA))
  9. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. (Hepatology)
  10. USE OF THE FIB4 INDEX FOR NON-INVASIVE EVALUATION OF FIBROSIS IN NONALCOHOLIC FATTY LIVER DISEASE (Clinical Gastroenterology and Hepatology)

Their papers